Video

How are data-centric approaches transforming the life sciences industry?

BioTechX 2022 panel discussion

9 November 2022, Basel
BioTechX panel discussion

This panel discussion covers the current challenges life sciences organizations are facing when it comes to adopting truly data-centric, cross functional approaches. The discussion also details arising opportunities for data-centric transformations and touches on some best practices for enabling data-centricity through the lens of patient impact, pre-competitive collaboration, and talent development.

This discussion took place on 9 November 2022 at BioTechX Europe in Basel. BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare.

"Organizations should be able to provide insights and knowledge to researchers and scientists in every area, across departments, from target identification to medical affairs, so decisions can be made faster so we can deliver for our patients."

Panel members

Najat Khan

Chief Data Science Officer, Global Head, Strategy and Operations

JANSSEN R&D

Angeli Moller

Head of Pharma International Informatics (PIIX)

ROCHE

Mahesh Pancholi

Chief Information Officer

UK BIOBANK

Najat Khan Biotech X Panel Discussion2022 (2)

Faisal Khan

Corporate Vice President Advanced Analytics,
AI and RWD

NOVO NORDISK

Moderated by

Bérénice Wulbrecht Vice-President OF SOLUTION DELIVERY
ONTOFORCE

Organizations should be able to provide insights and knowledge to researchers in every area, across departments, so decisions can be made faster for better patient outcomes.

Watch the recording

+140 trusted data sources in one easy-to-use platform

Try DISQOVER

How are data-centric approaches transforming the life sciences industry?

9 November 2022, Basel
BioTechX panel discussion

"Organizations should be able to provide insights and knowledge to researchers and scientists in every area, across departments, from target identification to medical affairs, so decisions can be made faster so we can deliver for our patients."